CONMED Corporation
CNMD
$44.50
$1.082.49%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.16% | -28.54% | -69.37% | 2.07% | 209.29% |
| Total Depreciation and Amortization | 3.52% | 4.10% | 1.19% | 1.86% | 0.57% |
| Total Amortization of Deferred Charges | -11.57% | -1.28% | 2.56% | -11.13% | -6.66% |
| Total Other Non-Cash Items | 152.23% | 1,222.22% | 872.18% | 855.23% | -303.34% |
| Change in Net Operating Assets | 1,664.35% | -218.86% | 105.49% | -520.64% | -33.53% |
| Cash from Operations | 4.85% | -32.73% | 42.63% | -23.15% | 11.00% |
| Capital Expenditure | -51.71% | -59.58% | -85.70% | 16.79% | 36.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -51.71% | -59.58% | -43.93% | 16.79% | 36.61% |
| Total Debt Issued | 16.78% | -1.63% | -34.65% | -16.67% | -20.99% |
| Total Debt Repaid | -15.98% | 7.97% | 24.12% | 15.45% | 20.66% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.42% | -0.45% | -0.44% | -0.46% | -0.29% |
| Other Financing Activities | -25.01% | 21.67% | 71.59% | 29.52% | -827.95% |
| Cash from Financing | -12.09% | 39.83% | -66.91% | 13.10% | -4.30% |
| Foreign Exchange rate Adjustments | -96.90% | 354.78% | 259.65% | -319.22% | 175.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.97% | 68.91% | 15.35% | -125.72% | 261.64% |